Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Recent Articles in Deals & Financings

CFIUS Approves Sino Biopharm’s Acquisition of F-Star after Nine Month Wait
Rinua Gene Raises $14.5 Million in Pre-A+ Round for mRNA Drugs
Abbisko Out-Licenses Precision EGFR-TKI Medicine to Allist in $188 Million Deal
TandemAI Raises $35 Million for AI/WetLab Drug Discovery Operations
Immorna Raises $100 Million for Clinical Trials of Novel RNA Candidates
ChinaBio Event
Singapore and Digital
April 26-27, 2023
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China